Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial.
- 2019-04
- RCT
- Journal of ethnopharmacology 234
- Ahmad Khonche
- Hasan Fallah Huseini
- Mahdi Gholamian
- Reza Mohtashami
- Farzaneh Nabati
- Saeed Kianbakht
- PubMed: 30639231
- DOI: 10.1016/j.jep.2019.01.009
- High evidence
- Clinical
the oil did not significantly affect the other outcome variables compared to the placebo (all P > 0.05)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 2.5 mL every 12 h